These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37038186)

  • 1. iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors.
    Bogomiakova ME; Sekretova EK; Anufrieva KS; Khabarova PO; Kazakova AN; Bobrovsky PA; Grigoryeva TV; Eremeev AV; Lebedeva OS; Bogomazova AN; Lagarkova MA
    Stem Cell Res Ther; 2023 Apr; 14(1):77. PubMed ID: 37038186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.
    Song C; Wang L; Li Q; Liao B; Qiao W; Li Q; Dong N; Li L
    Stem Cell Res Ther; 2022 Feb; 13(1):48. PubMed ID: 35109922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity.
    Flahou C; Morishima T; Takizawa H; Sugimoto N
    Front Immunol; 2021; 12():662360. PubMed ID: 33897711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives.
    Bogomiakova ME; Bogomazova AN; Lagarkova MA
    Biochemistry (Mosc); 2024 May; 89(5):799-816. PubMed ID: 38880643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of universal natural killer cells from a cryopreserved cord blood mononuclear cell-derived induced pluripotent stem cell library.
    Du W; Cui L; Zhang J; Zhang H; Liu R; Yang W; Zhang Y
    FEBS Open Bio; 2022 Oct; 12(10):1771-1781. PubMed ID: 35747945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs.
    Ichise H; Nagano S; Maeda T; Miyazaki M; Miyazaki Y; Kojima H; Yawata N; Yawata M; Tanaka H; Saji H; Masuda K; Kawamoto H
    Stem Cell Reports; 2017 Sep; 9(3):853-867. PubMed ID: 28867344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1.
    Kruse V; Hamann C; Monecke S; Cyganek L; Elsner L; Hübscher D; Walter L; Streckfuss-Bömeke K; Guan K; Dressel R
    PLoS One; 2015; 10(5):e0125544. PubMed ID: 25950680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced wound healing promotion by immune response-free monkey autologous iPSCs and exosomes vs. their allogeneic counterparts.
    Lu M; Peng L; Ming X; Wang X; Cui A; Li Y; Wang X; Meng D; Sun N; Xiang M; Chen S
    EBioMedicine; 2019 Apr; 42():443-457. PubMed ID: 30926422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Monkey Induced Pluripotent Stem Cell-Derived Cartilage Lacking Major Histocompatibility Complex Class I Molecules on the Cell Surface.
    Okutani Y; Abe K; Yamashita A; Morioka M; Matsuda S; Tsumaki N
    Tissue Eng Part A; 2022 Jan; 28(1-2):94-106. PubMed ID: 34182799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells.
    Flahou C; Morishima T; Higashi N; Hayashi Y; Xu H; Wang B; Zhang C; Ninomiya A; Qiu WY; Yuzuriha A; Suzuki D; Nakamura S; Manz M; Kaneko S; Hotta A; Takizawa H; Eto K; Sugimoto N
    Biochem Biophys Res Commun; 2023 Jun; 662():76-83. PubMed ID: 37099813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I
    Chimienti R; Baccega T; Torchio S; Manenti F; Pellegrini S; Cospito A; Amabile A; Lombardo MT; Monti P; Sordi V; Lombardo A; Malnati M; Piemonti L
    Cell Rep; 2022 Sep; 40(13):111423. PubMed ID: 36170817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Natural Killer Cells Differentiated from Various Pluripotent Stem Cells.
    Han J; Son H; Jung D; Kim KY; Jin C; Hwang H; Kang SS; Mitalipov S; An HJ; Lee Y; Kang E
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-Cell Mediated Immune Rejection of Beta-2-Microglobulin Knockout Induced Pluripotent Stem Cell-Derived Kidney Organoids.
    Gaykema LH; van Nieuwland RY; Lievers E; Moerkerk WBJ; de Klerk JA; Dumas SJ; Kers J; Zaldumbide A; van den Berg CW; Rabelink TJ
    Stem Cells Transl Med; 2024 Jan; 13(1):69-82. PubMed ID: 37843402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role of natural killer group 2D in recognition and cytotoxicity of hepatocyte-like cells derived from embryonic stem cells and induced pluripotent stem cells.
    Cisneros T; Dillard DW; Qu X; Arredondo-Guerrero J; Castro M; Schaffert S; Martin R; Esquivel CO; Krams SM; Martinez OM
    Am J Transplant; 2019 Jun; 19(6):1652-1662. PubMed ID: 30549427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.
    Goldenson BH; Zhu H; Wang YM; Heragu N; Bernareggi D; Ruiz-Cisneros A; Bahena A; Ask EH; Hoel HJ; Malmberg KJ; Kaufman DS
    Front Immunol; 2020; 11():561553. PubMed ID: 33178188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished expression of major histocompatibility complex facilitates the use of human induced pluripotent stem cells in monkey.
    Wang X; Lu M; Tian X; Ren Y; Li Y; Xiang M; Chen S
    Stem Cell Res Ther; 2020 Aug; 11(1):334. PubMed ID: 32746912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of NK cells in HIV-1 protection: autologous, allogeneic or both?
    Hens J; Jennes W; Kestens L
    AIDS Res Ther; 2016; 13():15. PubMed ID: 26997965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an induced pluripotent stem cell-specific microRNA assay for detection of residual undifferentiated cells in natural killer cell therapy products.
    Chung L; Cogburn LA; Sui L; Dashnau JL
    Cytotherapy; 2022 Jul; 24(7):733-741. PubMed ID: 35461759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.